TrialJCI insight2019
Changes in plasma lipids predict pravastatin efficacy in secondary prevention.
Kaushala S Jayawardana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled ittrialcites it
TrialJCI insight2019
Kaushala S Jayawardana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.